|
1
|
WHO-EORTC classification for cutaneous lymphomas.
|
Blood
|
2005
|
12.14
|
|
2
|
Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases.
|
Blood
|
2007
|
2.82
|
|
3
|
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3.
|
Blood
|
2005
|
1.83
|
|
4
|
Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC).
|
Arch Dermatol
|
2008
|
1.78
|
|
5
|
European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.
|
Blood
|
2008
|
1.73
|
|
6
|
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas.
|
J Clin Oncol
|
2006
|
1.70
|
|
7
|
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
|
Blood
|
2011
|
1.64
|
|
8
|
Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab).
|
Dermatology
|
2007
|
1.60
|
|
9
|
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.
|
J Cutan Pathol
|
2005
|
1.51
|
|
10
|
Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
|
Haematologica
|
2004
|
1.29
|
|
11
|
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
|
Cancer
|
2003
|
1.15
|
|
12
|
Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
|
Transplantation
|
2009
|
1.14
|
|
13
|
Twenty-one cases of blastic plasmacytoid dendritic cell neoplasm: focus on biallelic locus 9p21.3 deletion.
|
Blood
|
2011
|
1.12
|
|
14
|
Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma.
|
Clin Immunol
|
2006
|
1.06
|
|
15
|
Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
|
Histol Histopathol
|
2009
|
0.98
|
|
16
|
Skin involvement in cutaneous and systemic vasculitis.
|
Autoimmun Rev
|
2012
|
0.98
|
|
17
|
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type.
|
J Invest Dermatol
|
2008
|
0.94
|
|
18
|
Medallion-like dermal dendrocyte hamartoma: a case misdiagnosed as neurofibroma.
|
Pediatr Dermatol
|
2010
|
0.93
|
|
19
|
Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection.
|
Acta Derm Venereol
|
2010
|
0.93
|
|
20
|
Unusual variants of non-Langerhans cell histiocytoses.
|
J Am Acad Dermatol
|
2007
|
0.88
|
|
21
|
Gemcitabine as frontline treatment for cutaneous T-cell lymphoma: phase II study of 32 patients.
|
Cancer
|
2005
|
0.88
|
|
22
|
Cutaneous lupus erythematosus induced by adalimumab.
|
J Dermatol
|
2010
|
0.87
|
|
23
|
Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
|
J Am Acad Dermatol
|
2009
|
0.87
|
|
24
|
Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
|
Cancer
|
2012
|
0.87
|
|
25
|
Oral and cutaneous findings are valuable diagnostic aids in Wegener's granulomatosis.
|
Eur J Intern Med
|
2009
|
0.86
|
|
26
|
Chordoma cutis.
|
Eur J Dermatol
|
2004
|
0.86
|
|
27
|
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified.
|
Leuk Lymphoma
|
2011
|
0.85
|
|
28
|
Cetuximab-induced acneiform eruption and the response to isotretinoin.
|
Acta Derm Venereol
|
2008
|
0.84
|
|
29
|
Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
|
Hum Pathol
|
2002
|
0.82
|
|
30
|
Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.
|
Cancer Immunol Immunother
|
2013
|
0.82
|
|
31
|
Three cases of primary cutaneous lymphoblastic lymphoma: microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature.
|
Leuk Lymphoma
|
2011
|
0.81
|
|
32
|
Spatial and temporal expression of POF1B, a gene expressed in epithelia.
|
Gene Expr Patterns
|
2006
|
0.80
|
|
33
|
Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps.
|
Am J Rhinol
|
2006
|
0.80
|
|
34
|
Dermatologic radiotherapy of primary cutaneous follicle center cell lymphoma.
|
Eur J Dermatol
|
2003
|
0.79
|
|
35
|
C/EBPδ gene targets in human keratinocytes.
|
PLoS One
|
2010
|
0.79
|
|
36
|
Cutaneous T-cell/histiocyte-rich B-cell lymphoma: a case report and review of the literature.
|
Dermatology
|
2011
|
0.78
|
|
37
|
CLIPI: a new prognostic index for indolent cutaneous B cell lymphoma proposed by the International Extranodal Lymphoma Study Group (IELSG 11).
|
Ann Hematol
|
2010
|
0.78
|
|
38
|
Prevalence of Borrelia burgdorferi infection in a series of 98 primary cutaneous lymphomas.
|
Oncologist
|
2011
|
0.78
|
|
39
|
Cytokeratin profile in basal cell carcinoma.
|
Am J Dermatopathol
|
2008
|
0.77
|
|
40
|
Photoletter to the editor: Exfoliative cheilitis associated with titanium dental implants and mercury amalgam.
|
J Dermatol Case Rep
|
2011
|
0.76
|
|
41
|
Primary cutaneous follicular center cell lymphoma of the nose with maxillary sinus involvement in a pediatric patient.
|
J Am Acad Dermatol
|
2005
|
0.76
|
|
42
|
Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study.
|
Thromb Haemost
|
2015
|
0.76
|
|
43
|
Cytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds: Evidence for Autoinflammation.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
44
|
Refractory linear IgA bullous dermatosis successfully treated with mycophenolate sodium.
|
J Dermatolog Treat
|
2008
|
0.75
|
|
45
|
Paradoxical Autoinflammatory Skin Reaction to Tumor Necrosis Factor Alpha Blockers Manifesting as Amicrobial Pustulosis of the Folds in Patients With Inflammatory Bowel Diseases.
|
Medicine (Baltimore)
|
2015
|
0.75
|
|
46
|
Onycholemmal carcinoma.
|
Am J Dermatopathol
|
2004
|
0.75
|
|
47
|
High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
|
J Am Acad Dermatol
|
2005
|
0.75
|
|
48
|
Fatal CD8+ epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement.
|
Dermatology
|
2005
|
0.75
|
|
49
|
Role of radiotherapy in primary CD30+ and plemorphic small/medium-sized T-cell lymphomas.
|
Acta Derm Venereol
|
2005
|
0.75
|
|
50
|
Bcl-6 gene mutations in primary cutaneous B-cell lymphomas.
|
Haematologica
|
2004
|
0.75
|
|
51
|
Peristomal bullous pemphigoid.
|
J Dermatol
|
2010
|
0.75
|
|
52
|
Mycosis fungoides mimicking erythema gyratum repens: an additional variant?
|
Eur J Dermatol
|
2010
|
0.75
|
|
53
|
Pustular Skin Reaction to Tumor Necrosis Factor Alpha Antagonists in Patients with Inflammatory Bowel Diseases.
|
Inflamm Bowel Dis
|
2015
|
0.75
|
|
54
|
Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus.
|
Expert Rev Clin Immunol
|
2008
|
0.75
|